StockData
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS) stock

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30
$0.23+0.01 (+6.53%)

Close on Nov 17, 2026Market cap $16.64MP/E –Yield –

Acumen Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Acumen Pharmaceuticals's market cap was $16.63M on Nov 11, 2026, against $113.88M a year earlier. Over the last 5 years it ranged from $15.19M to $406.23M, with a median of $166.56M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.63M-87.0%
2025Dec 31, 2025$127.81M+23.7%
2024Dec 31, 2024$103.34M-53.5%
2023Dec 29, 2023$222.38M+1.7%
2022Dec 30, 2022$218.72M-20.1%
2021Dec 31, 2021$273.58M–

More Acumen Pharmaceuticals figures

See a number that looks wrong?